Celularity Inc (CELU)
3.00
-0.08
(-2.60%)
USD |
NASDAQ |
May 07, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Celularity Price to Book Value: 2.160 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.218 |
| May 03, 2024 | 2.369 |
| May 02, 2024 | 2.247 |
| May 01, 2024 | 2.175 |
| April 30, 2024 | 2.182 |
| April 29, 2024 | 2.160 |
| April 26, 2024 | 2.175 |
| April 25, 2024 | 2.211 |
| April 24, 2024 | 2.434 |
| April 23, 2024 | 2.312 |
| April 22, 2024 | 2.204 |
| April 19, 2024 | 2.182 |
| April 18, 2024 | 2.312 |
| April 17, 2024 | 2.384 |
| April 16, 2024 | 2.521 |
| April 15, 2024 | 3.025 |
| April 12, 2024 | 2.960 |
| April 11, 2024 | 3.349 |
| April 10, 2024 | 3.637 |
| April 09, 2024 | 3.889 |
| April 08, 2024 | 3.990 |
| April 05, 2024 | 3.831 |
| April 04, 2024 | 3.687 |
| April 03, 2024 | 3.795 |
| April 02, 2024 | 3.601 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.810 |
| March 28, 2024 | 3.766 |
| March 27, 2024 | 3.558 |
| March 26, 2024 | 3.622 |
| March 25, 2024 | 3.795 |
| March 22, 2024 | 3.738 |
| March 21, 2024 | 3.860 |
| March 20, 2024 | 3.939 |
| March 19, 2024 | 3.759 |
| March 18, 2024 | 4.033 |
| March 15, 2024 | 4.091 |
| March 14, 2024 | 4.105 |
| March 13, 2024 | 4.170 |
| March 12, 2024 | 4.245 |
| March 11, 2024 | 5.012 |
| March 08, 2024 | 4.451 |
| March 07, 2024 | 3.954 |
| March 06, 2024 | 3.097 |
| March 05, 2024 | 2.989 |
| March 04, 2024 | 3.068 |
| March 01, 2024 | 2.636 |
| February 29, 2024 | 2.578 |
| February 28, 2024 | 2.819 |
| February 27, 2024 | 2.982 |
| February 26, 2024 | 3.025 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3579
Minimum
Sep 29 2023
19.78
Maximum
Apr 28 2022
4.476
Average
2.370
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.924 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7653 |
| Theriva Biologics Inc | 0.2042 |
| Oragenics Inc | 3.896 |
Price to Book Value Related Metrics
| PS Ratio | 3.582 |
| PEG Ratio | -0.0006 |
| Price | 3.00 |
| Earnings Yield | -340.0% |
| Market Cap | 65.35M |
| PEGY Ratio | -0.0006 |